| Name: | arnica montana l. flower oil CO2 extract |
| CAS Number: | 68990-11-4 |
|
| ECHA EC Number: | 273-579-2 |
Category: fragrance agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | dark brown liquid (est) |
| Food Chemicals Codex Listed: | No |
| Soluble in: |
| | alcohol |
| Insoluble in: |
| | water |
Organoleptic Properties:
| |
| Odor Type: herbal |
| |
| Odor Strength: | medium |
| |
| | herbal sweet tea spicy |
Odor Description:
at 100.00 %. | herbal sweet tea spicy |
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
| FLAVEX Naturextrakte |
| Arnica Flower CO2-to extract (organic), 4 % Sesquiterpene lactones, DE-OKO-013 , Type No. 043.007
Odor: characteristic Use: The extract has analgetic, anti-arthritic, antibacterial, anti-inflammatory, antiseptic and antiplatelet properties. It is used for treatment of bruises, contusions, dislocations, hematoma, muscle soreness, backache, cramps, sprains, fibrositis, relief of muscle and joint pains and stiffness. It has blood circulation-enhancing effect and thus it is well suited for treatment of venous insufficiency.
Latest research in the field of chronic and age-related diseases proves the good efficacy in case of rheumatic and inflammatory conditions e.g. osteoarthritis.
Arnica should not be administered orally or applied to open wounds where absorption can occur.
(Statements summarise literature evidence and have informative character. They might be derived from invitro or animal testing and not be substantiated for humans. They don’t warrant end product properties. Statements have not been evaluated by the FDA. Formulations with this extract are not intended to diagnose, treat, cure or prevent any disease.) |
| FLAVEX Naturextrakte |
| Arnica Flower CO2-to extract, 4 % Sesquiterpene lactones, Type No. 043.002
Odor: characteristic Use: The extract has analgetic, anti-arthritic, antibacterial, anti-inflammatory, antiseptic and antiplatelet properties. It is used for treatment of bruises, contusions, dislocations, hematoma, muscle soreness, backache, cramps, sprains, fibrositis, relief of muscle and joint pains and stiffness. It has blood circulation-enhancing effect and thus it is well suited for treatment of venous insufficiency.
Latest research in the field of chronic and age-related diseases proves the good efficacy in case of rheumatic and inflammatory conditions e.g. osteoarthritis.
Arnica should not be administered orally or applied to open wounds where absorption can occur.
(Statements summarise literature evidence and have informative character. They might be derived from invitro or animal testing and not be substantiated for humans. They don’t warrant end product properties. Statements have not been evaluated by the FDA. Formulations with this extract are not intended to diagnose, treat, cure or prevent any disease.) |
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
Safety References:
References:
| | arnica montana l. flower oil CO2 extract |
| Canada Domestic Sub. List: | 68990-11-4 |
| Pubchem (sid): | 135320196 |
Other Information:
Potential Blenders and core components notePotential Uses:
Occurrence (nature, food, other): noteSynonyms:
| | arnica flower oil CO2 extract |
Articles:
|